Risk Factors for Melanoma Survival: DGCR8 as a Predictive Factor for Mortality in Young Patients
Acta Dermato-Venereologica · 2026
DOI: 10.2340/actadv.v106.44513 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Dermato-Venereologica, 2026. Verfasst von Fabiola Schafer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Specialties, School of Medicine, Universidad de La Frontera, Temuco, Chile. fdschafe@gmail.com. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Biomarkers, Tumor, RNA-Binding Proteins. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
MicroRNA-processing enzymes – Dicer and DGCR8 – have been found to be dysregulated in melanoma. This study investigated whether these microRNA-processing enzymes could be used as risk factors for mortality. A retrospective cohort including medical history and samples of 74 patients was reviewed. Clinical and pathological variables were compared with mortality. Percentage of immunoreactive tumour cells (%IRC) for each enzyme was evaluated using immunohistochemistry. A dichotomous breakdown of DGCR8 and Dicer expression (negative or positive test) was performed using a cut-off of 80% IRC. The 5-year survival rate of stage 0–I–II was 89.5% and stage III–IV was 18.5%. In the bivariate analysis, variables associated with lower survival were: aged over 42 years, histologic subtypes, Breslow thickness ≥ 0.8mm, ulceration, vascular invasion, metastatic melanoma, positive sentinel node, more than 1 positive node, LDH > 200 IU/L, distant metastasis, and stage III–IV. In the multivariate Cox model, the analysis for stage III–IV showed a significantly lower survival curve in patients with a positive DGCR8 test and aged ≤ 42 years (p = 0.0152, Wald test). The Cox proportional hazards model showed that a positive DGCR8 test was a predictive factor for mortality in patients aged ≤ 42 years (HR = 14.3, 95%CI 1.5–140, p = 0.024). This study highlights a potential biomarker for melanoma survival and its utility in stratifying high-risk patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Specialties, School of Medicine, Universidad de La Frontera, Temuco, Chile. fdschafe@gmail.com.
- Department of Pathological Anatomy, School of Medicine, Universidad de La Frontera, Temuco, Chile.
- Department of Pathological Anatomy, School of Medicine, Universidad de La Frontera, Temuco, Chile; Doctoral Program in Medical Science, Universidad de La Frontera, Temuco, Chile.
- Department of Public Health and Capacitación, Investigación y Gestión para la Salud Basada en Evidencias (CIGES), School of Medicine, Universidad de La Frontera, Temuco, Chile.
- School of Medicine, Faculty of Health Sciences and Center for Research, Innovation and Creation (CIIC), Universidad Católica de Temuco, Chile.
ORCID-Profile: Fabiola Schafer
Zitieren
APA
Schafer, F., Bellolio, E., Sepúlveda, T., Espinoza, M., Orellana, J. J., Villaseca, M. A., & Miranda, R. (2026). Risk Factors for Melanoma Survival: DGCR8 as a Predictive Factor for Mortality in Young Patients. Acta Dermato-Venereologica. https://doi.org/10.2340/actadv.v106.44513
Vancouver
Schafer F, Bellolio E, Sepúlveda T, Espinoza M, Orellana JJ, Villaseca MA, et al. Risk Factors for Melanoma Survival: DGCR8 as a Predictive Factor for Mortality in Young Patients. Acta Dermato-Venereologica. 2026. doi:10.2340/actadv.v106.44513
BibTeX
@article{Schafer2026,
author = {Schafer, Fabiola and Bellolio, Enrique and Sepúlveda, Tatiana and Espinoza, Mirta and Orellana, Juan-Jose and Villaseca, Miguel Angel and Miranda, Rodrigo},
title = {Risk Factors for Melanoma Survival: DGCR8 as a Predictive Factor for Mortality in Young Patients},
journal = {Acta Dermato-Venereologica},
year = {2026},
doi = {10.2340/actadv.v106.44513}
}
EUVIMED